May 26, 2016
May 26, 2016 —
Not all habits are bad. Some are even necessary. But inability to switch from acting habitually to acting in a deliberate way can underlie addiction and obsessive compulsive disorders. Working with a mouse model, an international team of researchers demonstrates what happens in the brain for habits to control behavior
November 9, 2023
November 9, 2023 —
The National Highway Traffic Safety Administration (NHTSA) estimates there were 42,795 deaths resulting from motor vehicle crashes in 2022 in the United States. This projection is close to the previous year fatality numbers, which were the highest in 16 years.
January 14, 2019
January 14, 2019 —
An international group that includes researchers at University of California San Diego School of Medicine has identified 124 genetic variants associated with a person’s willingness to take risks, as reported in a study published January 14, 2019 in Nature Genetics.
April 16, 2019
April 16, 2019 —
The University of California San Diego School of Global Policy and Strategy’s Center for U.S.-Mexican Studies recently released a report listing steps the U.S. and Mexico can take to make each other safe. The white paper lists 13 recommendations for both nations to achieve bilateral cooperation.
March 10, 2016
March 10, 2016 —
…Study, the Center for Cannabis Research, the Type 1 Diabetes Research Center, the Musculoskeletal Science Center, the Center for Multimodal Imaging and Genomics and the departments of gastroenterology, hepatology and ophthalmology. “This is a 21st century lab,” said Dr. David Brenner, Vice Chancellor of Health Sciences and Dean of the…
April 18, 2019
April 18, 2019 —
…on HIV and medicinal cannabis. Read More… Nineteen-hundred-and-sixty-nine was a famously memorable year. It was the year of Woodstock and the first man on the moon, of the Cuyahoga River in Cleveland catching fire and the last public performance by The Beatles—an impromptu concert atop Apple Records in London. It…
September 25, 2012
September 25, 2012 —
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
November 6, 2019
November 6, 2019 —
The University of California San Diego has announced its 2019 Entrepreneurs in Residence cohort. The EIR program brings outside expertise onto campus to help student and faculty entrepreneurs with their startups.